Explore

Trendline Trendline
Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Enhance Protein Degradation Platform

Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Enhance Protein Degradation Platform

Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Enhance Protein Degradation Platform
Trendline Trendline
Novartis CEO Joins Anthropic Board, Enhancing AI's Role in Biopharma

Novartis CEO Joins Anthropic Board, Enhancing AI's Role in Biopharma

Novartis CEO Joins Anthropic Board, Enhancing AI's Role in Biopharma
Trendline Trendline
ATUM Appoints Gavin Barnard as Chief Scientific Officer to Drive Biologics Innovation

ATUM Appoints Gavin Barnard as Chief Scientific Officer to Drive Biologics Innovation

ATUM Appoints Gavin Barnard as Chief Scientific Officer to Drive Biologics Innovation
Trendline Trendline
ATUM Appoints Gavin Barnard as Chief Scientific Officer to Enhance Biologics Development

ATUM Appoints Gavin Barnard as Chief Scientific Officer to Enhance Biologics Development

ATUM Appoints Gavin Barnard as Chief Scientific Officer to Enhance Biologics Development
Trendline Trendline
Ardena Expands U.S. Operations with New Bioanalytical Lab in New Jersey

Ardena Expands U.S. Operations with New Bioanalytical Lab in New Jersey

Ardena Expands U.S. Operations with New Bioanalytical Lab in New Jersey
Trendline Trendline
Byondis Showcases Novel ADC Technology at Cancer Research Meeting

Byondis Showcases Novel ADC Technology at Cancer Research Meeting

Byondis Showcases Novel ADC Technology at Cancer Research Meeting
Trendline Trendline
Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey

Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey

Ardena Expands Bioanalytical Capabilities with New Laboratory in New Jersey
Trendline Trendline
Kivu Bioscience to Showcase ADC Innovations at AACR Annual Meeting 2026

Kivu Bioscience to Showcase ADC Innovations at AACR Annual Meeting 2026

Kivu Bioscience to Showcase ADC Innovations at AACR Annual Meeting 2026
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs
Trendline Trendline
Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements

Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements

Kivu Bioscience Appoints Mohit Trikha as CEO to Drive Oncology Advancements
Trendline Trendline
Kivu Bioscience Appoints Mohit Trikha as CEO to Lead ADC Development

Kivu Bioscience Appoints Mohit Trikha as CEO to Lead ADC Development

Kivu Bioscience Appoints Mohit Trikha as CEO to Lead ADC Development
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with ADC Technology

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with ADC Technology

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with ADC Technology